BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 28964936)

  • 1. Discovery of 2-phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate.
    Cernicchi G; Rampacci E; Massari S; Manfroni G; Barreca ML; Tabarrini O; Cecchetti V; Felicetti T; Di Luca M; Poma NV; Tavanti A; Passamonti F; Rindi L; Sabatini S
    Arch Pharm (Weinheim); 2024 Jun; ():e2400296. PubMed ID: 38923553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux pump effects on levofloxacin resistance in
    Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
    Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.
    Monteiro KLC; Silva ON; Dos Santos Nascimento IJ; Mendonça Júnior FJB; Aquino PGV; da Silva-Júnior EF; de Aquino TM
    Curr Top Med Chem; 2022; 22(24):1983-2028. PubMed ID: 35319372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents.
    Millanao AR; Mora AY; Villagra NA; Bucarey SA; Hidalgo AA
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives.
    Cernicchi G; Felicetti T; Sabatini S
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoids as Inhibitors of Bacterial Efflux Pumps.
    Waditzer M; Bucar F
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemicals: A Promising Weapon in the Arsenal against Antibiotic-Resistant Bacteria.
    Khameneh B; Eskin NAM; Iranshahy M; Fazly Bazzaz BS
    Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
    Solnier J; Martin L; Bhakta S; Bucar F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-2 phenyl replacements to obtain potent quinoline-based
    Felicetti T; Mangiaterra G; Cannalire R; Cedraro N; Pietrella D; Astolfi A; Massari S; Tabarrini O; Manfroni G; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):584-597. PubMed ID: 31992093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives Regarding the Role of Biochanin A in Humans.
    Yu C; Zhang P; Lou L; Wang Y
    Front Pharmacol; 2019; 10():793. PubMed ID: 31354500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on plant antimicrobials: a mechanistic viewpoint.
    Khameneh B; Iranshahy M; Soheili V; Fazly Bazzaz BS
    Antimicrob Resist Infect Control; 2019; 8():118. PubMed ID: 31346459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants.
    Felicetti T; Machado D; Cannalire R; Astolfi A; Massari S; Tabarrini O; Manfroni G; Barreca ML; Cecchetti V; Viveiros M; Sabatini S
    ACS Infect Dis; 2019 Jun; 5(6):982-1000. PubMed ID: 30907573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium.
    Machado D; Cannalire R; Santos Costa S; Manfroni G; Tabarrini O; Cecchetti V; Couto I; Viveiros M; Sabatini S
    ACS Infect Dis; 2015 Dec; 1(12):593-603. PubMed ID: 27623057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
    Lechner D; Gibbons S; Bucar F
    J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective.
    Kapp E; Malan SF; Joubert J; Sampson SL
    Mini Rev Med Chem; 2018; 18(1):72-86. PubMed ID: 28494730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
    Rindi L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
    Cannalire R; Machado D; Felicetti T; Santos Costa S; Massari S; Manfroni G; Barreca ML; Tabarrini O; Couto I; Viveiros M; Sabatini S; Cecchetti V
    Eur J Med Chem; 2017 Nov; 140():321-330. PubMed ID: 28964936
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.